 Elizabeth Gillespie
Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disinfection | 7 | 2017 | 107 | 2.570 |
Why?
| | Infection Control | 12 | 2016 | 132 | 2.490 |
Why?
| | Cross Infection | 10 | 2022 | 194 | 2.440 |
Why?
| | Housekeeping, Hospital | 5 | 2019 | 5 | 2.410 |
Why?
| | Disease Outbreaks | 8 | 2017 | 305 | 1.690 |
Why?
| | Equipment Contamination | 6 | 2016 | 54 | 1.560 |
Why?
| | Environmental Microbiology | 4 | 2015 | 43 | 1.450 |
Why?
| | Decontamination | 2 | 2016 | 23 | 1.010 |
Why?
| | Intensive Care Units | 4 | 2015 | 614 | 0.980 |
Why?
| | Health Facilities | 3 | 2015 | 71 | 0.970 |
Why?
| | Steam | 5 | 2017 | 8 | 0.960 |
Why?
| | Sterilization | 2 | 2014 | 11 | 0.900 |
Why?
| | Operating Rooms | 2 | 2015 | 85 | 0.860 |
Why?
| | Allergists | 1 | 2022 | 19 | 0.780 |
Why?
| | Gram-Positive Bacterial Infections | 3 | 2017 | 61 | 0.730 |
Why?
| | Vancomycin-Resistant Enterococci | 2 | 2017 | 2 | 0.680 |
Why?
| | Australia | 7 | 2017 | 205 | 0.590 |
Why?
| | Cost-Benefit Analysis | 3 | 2016 | 544 | 0.580 |
Why?
| | Public Health | 1 | 2022 | 433 | 0.570 |
Why?
| | Duodenoscopes | 1 | 2016 | 7 | 0.540 |
Why?
| | Disease Transmission, Infectious | 1 | 2017 | 54 | 0.530 |
Why?
| | Enterobacteriaceae Infections | 1 | 2016 | 33 | 0.530 |
Why?
| | Medical Waste Disposal | 1 | 2016 | 1 | 0.520 |
Why?
| | Bedding and Linens | 1 | 2016 | 9 | 0.520 |
Why?
| | Luminescent Measurements | 1 | 2016 | 74 | 0.520 |
Why?
| | Bacteremia | 3 | 2022 | 160 | 0.510 |
Why?
| | Maintenance and Engineering, Hospital | 1 | 2015 | 2 | 0.490 |
Why?
| | Durable Medical Equipment | 1 | 2015 | 4 | 0.490 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 2016 | 180 | 0.470 |
Why?
| | Adenosine Triphosphate | 1 | 2016 | 428 | 0.460 |
Why?
| | Disposable Equipment | 1 | 2014 | 15 | 0.460 |
Why?
| | Patient Isolation | 1 | 2014 | 18 | 0.450 |
Why?
| | Silver | 1 | 2014 | 27 | 0.450 |
Why?
| | Environmental Monitoring | 1 | 2015 | 255 | 0.440 |
Why?
| | Disinfectants | 1 | 2014 | 34 | 0.440 |
Why?
| | Staphylococcal Infections | 3 | 2022 | 340 | 0.440 |
Why?
| | Fluorescent Dyes | 2 | 2014 | 298 | 0.440 |
Why?
| | Anti-Infective Agents | 1 | 2016 | 219 | 0.430 |
Why?
| | Perioperative Nursing | 1 | 2013 | 2 | 0.420 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 246 | 0.420 |
Why?
| | Sutures | 1 | 2013 | 50 | 0.410 |
Why?
| | Hair | 1 | 2013 | 65 | 0.410 |
Why?
| | Health Personnel | 2 | 2015 | 569 | 0.400 |
Why?
| | Drug Therapy | 1 | 2012 | 74 | 0.400 |
Why?
| | Hand Disinfection | 3 | 2013 | 22 | 0.380 |
Why?
| | Reference Standards | 1 | 2011 | 159 | 0.370 |
Why?
| | Bacterial Infections | 1 | 2012 | 217 | 0.360 |
Why?
| | Nurses | 1 | 2012 | 145 | 0.350 |
Why?
| | Guideline Adherence | 3 | 2008 | 489 | 0.320 |
Why?
| | Methicillin Resistance | 2 | 2008 | 19 | 0.300 |
Why?
| | Humans | 33 | 2022 | 114050 | 0.300 |
Why?
| | Medical Staff, Hospital | 2 | 2008 | 74 | 0.300 |
Why?
| | Bacteria | 1 | 2014 | 725 | 0.290 |
Why?
| | Equipment Reuse | 1 | 2007 | 11 | 0.290 |
Why?
| | Victoria | 7 | 2022 | 15 | 0.290 |
Why?
| | Endoscopes | 1 | 2007 | 18 | 0.290 |
Why?
| | Clostridium Infections | 2 | 2022 | 54 | 0.280 |
Why?
| | Chlorhexidine | 1 | 2007 | 22 | 0.280 |
Why?
| | Serratia Infections | 1 | 2007 | 6 | 0.280 |
Why?
| | Serratia marcescens | 1 | 2007 | 12 | 0.280 |
Why?
| | Anti-Infective Agents, Local | 1 | 2007 | 39 | 0.280 |
Why?
| | Nursing Staff, Hospital | 2 | 2008 | 123 | 0.270 |
Why?
| | Homes for the Aged | 3 | 2017 | 19 | 0.270 |
Why?
| | Staphylococcus aureus | 3 | 2022 | 385 | 0.270 |
Why?
| | Influenza, Human | 2 | 2014 | 543 | 0.270 |
Why?
| | Endoscopy | 1 | 2007 | 245 | 0.250 |
Why?
| | Attitude of Health Personnel | 2 | 2012 | 970 | 0.240 |
Why?
| | Anti-Bacterial Agents | 2 | 2016 | 1471 | 0.230 |
Why?
| | Time Factors | 4 | 2016 | 6077 | 0.210 |
Why?
| | Carrier State | 2 | 2015 | 54 | 0.210 |
Why?
| | Quality of Health Care | 1 | 2007 | 572 | 0.210 |
Why?
| | Extreme Heat | 1 | 2022 | 1 | 0.200 |
Why?
| | Heat Stress Disorders | 1 | 2022 | 40 | 0.190 |
Why?
| | Colony Count, Microbial | 2 | 2014 | 111 | 0.180 |
Why?
| | Climate Change | 1 | 2022 | 118 | 0.170 |
Why?
| | Safety Management | 1 | 2019 | 106 | 0.150 |
Why?
| | Parainfluenza Virus 3, Human | 1 | 2016 | 5 | 0.140 |
Why?
| | Respirovirus Infections | 1 | 2016 | 21 | 0.140 |
Why?
| | Textiles | 1 | 2017 | 19 | 0.140 |
Why?
| | Bacteriological Techniques | 1 | 2017 | 63 | 0.130 |
Why?
| | Medical Waste | 1 | 2016 | 1 | 0.130 |
Why?
| | Urinary Tract Infections | 1 | 2017 | 131 | 0.130 |
Why?
| | Gram-Positive Bacteria | 1 | 2016 | 45 | 0.130 |
Why?
| | Environment, Controlled | 1 | 2015 | 19 | 0.130 |
Why?
| | Gram-Negative Bacteria | 1 | 2016 | 66 | 0.130 |
Why?
| | Enterococcus faecium | 1 | 2015 | 10 | 0.120 |
Why?
| | Quality Control | 1 | 2015 | 143 | 0.120 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 413 | 0.120 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 771 | 0.120 |
Why?
| | Enterococcus | 2 | 2011 | 18 | 0.110 |
Why?
| | Infant, Newborn | 3 | 2017 | 5038 | 0.110 |
Why?
| | Masks | 1 | 2014 | 46 | 0.110 |
Why?
| | Equipment and Supplies, Hospital | 1 | 2013 | 5 | 0.110 |
Why?
| | Caliciviridae Infections | 1 | 2013 | 17 | 0.110 |
Why?
| | Norovirus | 1 | 2013 | 23 | 0.110 |
Why?
| | Floors and Floorcoverings | 1 | 2012 | 3 | 0.100 |
Why?
| | Enterobacteriaceae | 1 | 2013 | 33 | 0.100 |
Why?
| | Drug Resistance, Microbial | 1 | 2013 | 66 | 0.100 |
Why?
| | Catheter-Related Infections | 1 | 2013 | 61 | 0.100 |
Why?
| | Gastroenteritis | 1 | 2013 | 65 | 0.100 |
Why?
| | Professional Competence | 1 | 2012 | 81 | 0.100 |
Why?
| | Catheterization, Peripheral | 1 | 2013 | 100 | 0.100 |
Why?
| | Ultraviolet Rays | 1 | 2014 | 363 | 0.100 |
Why?
| | Polymers | 1 | 2015 | 448 | 0.100 |
Why?
| | Pilot Projects | 2 | 2014 | 1360 | 0.100 |
Why?
| | Education, Medical, Continuing | 1 | 2012 | 115 | 0.090 |
Why?
| | Hospitals | 1 | 2016 | 581 | 0.090 |
Why?
| | Staining and Labeling | 1 | 2011 | 134 | 0.090 |
Why?
| | Escherichia coli Infections | 1 | 2011 | 102 | 0.090 |
Why?
| | Environment | 1 | 2012 | 333 | 0.090 |
Why?
| | Drug Resistance, Bacterial | 1 | 2011 | 156 | 0.090 |
Why?
| | Nursing Homes | 1 | 2011 | 138 | 0.090 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2015 | 176 | 0.090 |
Why?
| | Bacterial Proteins | 1 | 2015 | 735 | 0.080 |
Why?
| | Influenza Vaccines | 1 | 2014 | 497 | 0.080 |
Why?
| | Skin Care | 1 | 2008 | 18 | 0.080 |
Why?
| | Health Services Research | 1 | 2011 | 373 | 0.080 |
Why?
| | Neoplasms | 1 | 2022 | 2086 | 0.080 |
Why?
| | Infectious Disease Transmission, Professional-to-Patient | 1 | 2008 | 5 | 0.070 |
Why?
| | Aged | 6 | 2022 | 18971 | 0.070 |
Why?
| | Vaccination | 1 | 2014 | 1202 | 0.060 |
Why?
| | Delivery of Health Care | 2 | 2022 | 828 | 0.060 |
Why?
| | Critical Care | 1 | 2008 | 472 | 0.060 |
Why?
| | Seasons | 1 | 2007 | 440 | 0.060 |
Why?
| | Male | 9 | 2016 | 55400 | 0.050 |
Why?
| | Practice Guidelines as Topic | 2 | 2008 | 1381 | 0.050 |
Why?
| | Tertiary Care Centers | 2 | 2014 | 126 | 0.050 |
Why?
| | Arizona | 1 | 2022 | 68 | 0.050 |
Why?
| | Female | 8 | 2016 | 59328 | 0.050 |
Why?
| | Hot Temperature | 1 | 2022 | 301 | 0.040 |
Why?
| | Risk Factors | 3 | 2022 | 8614 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2016 | 6307 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 378 | 0.040 |
Why?
| | Incidence | 2 | 2013 | 2314 | 0.030 |
Why?
| | Epidemiological Monitoring | 1 | 2016 | 46 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2007 | 4595 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 799 | 0.030 |
Why?
| | Multilocus Sequence Typing | 1 | 2015 | 12 | 0.030 |
Why?
| | Drug Utilization | 1 | 2016 | 164 | 0.030 |
Why?
| | Middle Aged | 3 | 2013 | 26607 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2016 | 217 | 0.030 |
Why?
| | Molecular Epidemiology | 1 | 2015 | 62 | 0.030 |
Why?
| | Genome, Bacterial | 1 | 2015 | 106 | 0.030 |
Why?
| | Population Surveillance | 1 | 2017 | 385 | 0.030 |
Why?
| | Adolescent | 2 | 2013 | 17802 | 0.030 |
Why?
| | Adult | 3 | 2013 | 30377 | 0.030 |
Why?
| | Carbapenems | 1 | 2013 | 16 | 0.030 |
Why?
| | beta-Lactamases | 1 | 2013 | 25 | 0.030 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2013 | 36 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 722 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2013 | 302 | 0.020 |
Why?
| | beta-Lactam Resistance | 1 | 2011 | 6 | 0.020 |
Why?
| | Immunization Programs | 1 | 2014 | 204 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2013 | 300 | 0.020 |
Why?
| | Vancomycin Resistance | 1 | 2011 | 15 | 0.020 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2011 | 61 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1757 | 0.020 |
Why?
| | Medical Audit | 1 | 2008 | 75 | 0.020 |
Why?
| | Gram-Negative Aerobic Bacteria | 1 | 2008 | 5 | 0.020 |
Why?
| | Hospital Units | 1 | 2008 | 23 | 0.020 |
Why?
| | Clothing | 1 | 2008 | 19 | 0.020 |
Why?
| | United States | 1 | 2022 | 12137 | 0.020 |
Why?
| | Prevalence | 1 | 2011 | 2247 | 0.020 |
Why?
| | Risk Assessment | 1 | 2013 | 2958 | 0.010 |
Why?
| | Infant | 1 | 2015 | 7944 | 0.010 |
Why?
| | Prospective Studies | 1 | 2013 | 6195 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 12521 | 0.010 |
Why?
| | Young Adult | 1 | 2013 | 10446 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 4402 | 0.010 |
Why?
|
|
Gillespie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|